WHO ICTRP trial
Influence of intensity-modulated radiotherapy (IMRT) on xerostomia, salivary pH…
DRKS00037661 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00037661 |
|---|---|
| Public title | Influence of intensity-modulated radiotherapy (IMRT) on xerostomia, salivary pH, and quality of life in patients with tumors of the oral cavity and pharynx (pre- and post-IMRT). |
| Scientific title | Influence of intensity-modulated radiotherapy (IMRT) on xerostomia, salivary pH, and quality of life in patients with tumors of the oral cavity and pharynx (pre- and post-IMRT). - IMRT saliva |
| Primary sponsor | UKB Poliklinik für Zahnärztliche Prothetik |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | C10;Malignant neoplasm of oropharynx |
| Interventions | Group 1: In patients receiving radiotherapy in the head and neck region, salivary flow rate, salivary pH, and questionnaires (oral health, salivary flow rate) are measured at T0, T1, T2, and T3. |
| Registration date | Nov 8, 2025 |
| Target size | 40 |
| Secondary IDs | 2025-102-BO |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: